Laboratory Information System (LIS)
Laboratory Information System (LIS) Integration for Rapid Point-of-Care Diagnostics
Seamless Laboratory Information System (LIS) Integration for Connected Healthcare
At OncoFirm™ Diagnostics, we are implementing Laboratory Information System (LIS) integration framework designed to seamlessly connect our point-of-care (POC) cancer diagnostic platform with hospital, laboratory, and healthcare information systems. Our integration architecture is intended to support industry-standard communication protocols, including HL7®, ASTM, and FHIR®, enabling secure, automated exchange of patient information, diagnostic results, instrument status, and laboratory workflow data.
By integrating the OncoFirm™ Electronic Reader with existing Laboratory Information Systems (LIS), Electronic Medical Records (EMR), and Electronic Health Records (EHR), healthcare providers can reduce manual data entry, minimize transcription errors, accelerate reporting, and improve clinical decision-making through faster access to accurate diagnostic information.
Intelligent Data Connectivity for Modern Clinical Laboratories
The OncoFirm™ Electronic Reader is being engineered to automatically capture, analyze, and digitally interpret fluorescence-based lateral flow assay results with laboratory-grade consistency.
The platform is intended to securely record:
- Patient demographics
- Test orders and accession information
- Diagnostic test results
- Operator identification
- Quality control (QC) records
- Calibration history
- Instrument performance metrics
- Date and time stamps
- Audit trail documentation
Through seamless LIS, EMR, and EHR integration, these records can be automatically synchronized across healthcare systems, creating a comprehensive digital workflow that supports laboratory accreditation, quality assurance, regulatory compliance, and long-term patient record management.
Faster Reporting Through Automated Laboratory Workflows
Modern clinical laboratories require rapid, reliable communication between diagnostic instruments and healthcare information systems.
Our planned LIS connectivity is intended to:
- Eliminate manual transcription of diagnostic results
- Reduce reporting errors
- Improve laboratory efficiency
- Accelerate turnaround time (TAT)
- Streamline physician reporting
- Improve communication between laboratories and healthcare providers
- Enhance patient care through faster diagnostic reporting
By automating the transfer of diagnostic data, laboratories can improve operational efficiency while maintaining data accuracy and traceability.
Secure Healthcare Data Exchange and Cybersecurity
Protecting patient information is fundamental to every healthcare environment.
The OncoFirm™ LIS integration framework is being designed with enterprise-grade cybersecurity features, including:
- End-to-end encrypted data transmission
- Role-based user authentication
- Secure cloud synchronization
- Comprehensive audit logging
- Controlled administrative access
- Instrument monitoring and remote diagnostics
- Secure software updates
- Multi-site deployment management
The architecture is intended to support both on-premises hospital networks and cloud-enabled healthcare infrastructures, allowing hospitals, physician offices, oncology clinics, diagnostic laboratories, and decentralized testing facilities to deploy the platform according to their IT security policies.
Interoperability Across Healthcare Systems
Healthcare organizations increasingly depend on interoperable diagnostic systems.
OncoFirm™ Diagnostics is developing a platform intended to integrate with:
- Hospital Laboratory Information Systems (LIS)
- Electronic Medical Records (EMR)
- Electronic Health Records (EHR)
- Hospital Information Systems (HIS)
- Laboratory middleware platforms
- Clinical data repositories
- Cloud-based healthcare platforms
Support for HL7®, ASTM, and FHIR® interoperability standards is intended to simplify deployment while reducing integration complexity for healthcare IT teams.
AI-Enabled Clinical Intelligence and Population Health Analytics
Beyond secure laboratory connectivity, OncoFirm™ envisions its LIS integration as the foundation for future AI-powered diagnostic intelligence.
Using appropriately governed and privacy-protected diagnostic datasets, future platform capabilities may include:
- AI-assisted clinical decision support
- Biomarker trend analysis
- Laboratory quality monitoring
- Population health surveillance
- Clinical performance analytics
- Predictive healthcare insights
- Oncology research support
- Multi-site laboratory benchmarking
These planned capabilities are intended to help healthcare organizations improve diagnostic quality while supporting biomarker research and precision oncology initiatives.
Supporting the Future of Precision Oncology
As healthcare continues to transition toward connected digital ecosystems, seamless interoperability between diagnostic devices and clinical information systems is becoming increasingly important.
By combining rapid fluorescence lateral flow diagnostics, secure Laboratory Information System (LIS) integration, cloud connectivity, and future AI-assisted analytics, OncoFirm™ Diagnostics is building a platform intended to enhance laboratory efficiency, improve diagnostic workflows, support precision oncology, and help healthcare providers deliver faster, more informed patient care.
The OncoFirm™ platform is currently under development. Certain capabilities described represent intended design objectives and future functionality and may be subject to regulatory review and product development milestones.
